Results 121 to 130 of about 280,456 (250)
PCSK9 monoclonal antibodies and lipoprotein apheresis for lowering lipoprotein(a): making choices in an era of RNA-based therapies [PDF]
Massimiliano Ruscica +2 more
openalex +1 more source
Familial hypercholesterolemia, a genetic disorder marked by elevated low-density lipoprotein cholesterol (LDL-C), poses significant risks for premature atherosclerosis and cardiovascular diseases, particularly during pregnancy. One of the safe methods of
Milos Milincic +6 more
doaj +1 more source
Egy ritka, veleszületett neurodegeneratív betegség: a cerebrotendinosus xanthomatosis laboratóriumi diagnosztikája [PDF]
Cerebrotendinous xanthomatosis is a rare neurodegenerative disease characterized by the accumulation of cholesterol and cholestanol in the brain and the tendons caused by mutations of the gene encoding sterol 27-hydroxylase (CYP27A1), which is involved ...
Balogh István +10 more
core +1 more source
Contact Activation in Low‐density Lipoprotein Apheresis Systems
Abstract: Background: Anaphylactoid reactions due to contact activation have been observed in patients on ACE inhibitor therapy and hemodialysis with negatively charged dialysis membranes. Negatively charged surfaces are functional constituents of different LDL apheresis systems.
Krieter, D. H. +7 more
openaire +3 more sources
Commentary: Effects of lipoprotein apheresis on PCSK9 levels [PDF]
Ulrich Julius
openalex +1 more source
[State of the art: lipoprotein apheresis]. [PDF]
Schatz U, Schettler VJJ, Julius U.
europepmc +1 more source
Commentary: Effects of different lipoprotein apheresis methods on serum protein levels [PDF]
Ulrich Julius
openalex +1 more source
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source

